Evidence map›Paper›PMID 42519198›Full record

ArticleFrontiers in psychiatry2026

Updated Freudian drive theory: childhood trauma, epigenetics, serotonin and beta endorphin.

Michael Kirsch

Abstract read
In one paragraph

Article in Frontiers in psychiatry, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author.

Michael KirschMedical Faculty of the University of Cologne, Department of Anesthesiology and Intensive Care Medicine, University Hospital of Cologne, Cologne, Germany.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Sigmund Freud developed Drive Theory from clinical observations and proposed that a limited set of basic drives, including hunger, thirst, sleep, sexuality, and attachment, contributes to psychological stability. Modern reinterpretations allow these drives to be discussed alongside neurobiological regulation, including serotonergic and opioidergic signalling, which are relevant to depressive disorders. Selective serotonin reuptake inhibitors remain a common first line pharmacological option, yet treatment response varies, and simplified deficiency accounts are debated in the current literature. Early adversity is a transdiagnostic risk factor for affective disorders and may contribute to a subtype of depression in which attachment disturbance is prominent. In this context, trauma related epigenetic modifications have been reported in genes involved in serotonergic signalling and related pathways. Reduced serotonergic regulation may be linked to diminished β-endorphin tone, a mechanism discussed in clinical and translational work. Such opioid hypoactivity may also help to frame comorbid behaviours, including overeating and substance use, as short term compensatory attempts rather than independent primary disorders. This manuscript proposes a revised Freudian Drive Theory to describe trauma related depression as a disorder of impaired attachment related motivation with downstream effects on β-endorphin mediated satisfaction. The model is intended to provide a clinically oriented explanatory model. It generates testable predictions and may help to clarify why pharmacological response differs across trauma related presentations, while emphasizing the complementary role of psychotherapy in addressing attachment difficulties, interpersonal functioning, and emotion regulation.

Indexed as

attachment dysregulationFreudian drivesmu-opioid signallingtrauma-related depressionβ-endorphin

Identifiers

PMID42519198
PMCPMC13382637

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.